S1PR1 and systemic sclerosis: S1PR1-aAb appeared unrelated to PAH, and prevalence in the SSc w/o PAH group (18/100, 18.0%) was similar to the prevalence in the SSc-PAH group (9/58, 15.5%) (Figure 4A).